Recon: US Patent Office to review Novo Nordisk semaglutide patent; WHO portal aims to simplify prequalification process
ReconJason Scott
Advanced therapies/cell and gene therapyAfricaAPIsAsiaBiologics/ biosimilars/ vaccinesBiotechnologyCanadaCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIEuropeGenericsGlobalLatin America/CaribbeanMedical DevicesMiddle EastNorth AmericaNutritional/Natural HealthOceaniaOTCOtherPharmaceuticalsRegulatory Intelligence/PolicyUnited States